NCT00577122 2023-10-16
Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
Indiana University
Phase 2 Completed
Indiana University
Yale University
Kayseri Education and Research Hospital
GOG Foundation
Takeda
Merck Sharp & Dohme LLC
Centre Leon Berard